Rheumatoid arthritis has a prevalence of about 0.5%-1% among adults worldwide. 3 The prevalence of RA in women is about 2-3 times higher than in men. 4 In addition, many studies have pointed out that the incidence rates of different ethnic groups vary greatly from country to country, with incidence rates of: 0.9%-1.1% in the USA, UK, Finland, Denmark and Sweden; 0.4%-0.6% in other European countries; 0.1%-0.5% in South American countries; 0.1%-0.3% in Asian countries; 0%-0.3% in Africa. 5, 6 These data indicate that RA has a higher incidence rate among Caucasians in Europe and America, and a lower incidence among Asian and African populations. It also indicates that the risk of RA is associated with genetic backgrounds.
Although the causes and mechanisms of RA have not been clarified, genetic inheritance is an important factor in RA susceptibility, as revealed by experiments with twins and affected siblings abroad. 7 Twin studies have shown that identical twins exhibit RA concordance four-fold more than fraternal twins. 7 Current research mainly focuses on the classic human leukocyte antigen (HLA) gene, as well
as other genes such as Fc receptor-like protein 3 (FCRL3) and protein tyrosine phosphatase, non-receptor type 22 (PTPN22). PTPN22 located in chromosome 1 at 1p13 encodes a specific lymphophosphatase that inhibits T cell receptor signaling by interacting with the SH3 region of C-terminal Src kinase (CSK) through a phosphatase contained in its own motif. 8 Studies have previously found that the PTPN22 gene is involved in autoimmune diseases. 9 Its genetic variants have been linked to systemic lupus erythematosus, 10 generalized vitiligo, 11 Graves' disease, 12 type 1 diabetes, 13 and RA. 14 In addition, another site in PTPN22 is differently associated with RA in various countries. [15] [16] [17] [18] Therefore, the polymorphisms of PTPN22 may also be risk indicators for autoimmune diseases.
Genetic differences for RA incidence among the different ethnicities may be due to different sensitivities to PTPN22-1123. Different ethnicities can be used in subgroup analysis to determine the impact of different races on the results so that the results are more reliable. However, no meta-analysis about the incidence of RA and PTPN22-1123 has been reported. Therefore, we hypothesized that carrying the PTPN22-1123 variant had an association with the development of RA, and the association was differently affected by ethnicity. The hypothesis was examined by conducting a meta-analysis of all the case-control studies and KARE data from Korea since no study has reported the association between RA and PTPN22-1123.
According to an online search, this will be the first meta-analysis of the association between RA and PTPN22-1123. and Medical Sub Headings (MeSH) used for extracting the articles were "PTPN22", "rheumatoid arthritis", "arthritis", "1123G/C" and "rs2488457". All documents were published from 1 January, 2001
| MATERIAL S AND ME THODS

| Publication search and inclusion criteria for RA
to 31 July, 2018. 
| Eligibility criteria for studies for this review
The following criteria were used to select the publications for the meta-analysis: (a) the literature selected from peer-reviewed journals; (b) the study evaluated the relationship between PTPN22-1123 polymorphism and RA; and (c) the studies having Hardy-Weinberg equilibrium (HWE) P value of >0.05.
| Data extraction
ZT and QJY independently searched for proper publications from the database by keyword literature search. WXG reviewed the extracted data and had a responsibility to confirm the satisfaction of meta-analytical criteria. Contradictions arising from data extraction and data analysis were reconciled by the third reviewer (WXG)
and SP Duplicated articles were removed and only one article from the same study was included. After adopting the recommendations of the third reviewer, it was classified by major, heterozygote, and minor alleles. According to ethnicity, major and minor alleles were different in PTPN22-1123G/C. However, the risk allele was determined by the articles and the C allele of PTPN22-1123G/C was the risk allele regardless of ethnicity. [15] [16] [17] [18] [21] [22] [23] [24] [25] The extracted articles included the author's name, publication time, country of the subject, diagnostic criteria, number of genotypes, total number of subjects of case and control groups.
| Quality assessment and publication bias of selected articles
The quality of individual research affected the statistical sig- Through the conclusions of all the authors of the article, it is found that irrelevant race C was a risk factor, so the risk factor and non-risk factor were entered and analyzed.
| Statistical analyses
been diagnosed for RA?" was surveyed. We conducted genetic 
| RE SULTS
| Summary of included studies
The process of selecting articles to include in the meta-analysis is shown in Figure 1 . A total of 489 total articles were found after searching the databases using the keywords. In the initial screening of the articles, 176 articles were removed due to duplication in multiple databases. After reviewing the abstracts of 313 articles, 203 articles were excluded due to gene-environmental interactions (n = 13), not RA disease (n = 76), RA being combined with other diseases (n = 5), different genetic variants (n = 57), different pathogenic factors (n = 6), gene-related study (n = 34) and insufficient data due to abstracts only (n = 12). The full texts were reviewed in the remaining 110 manuscripts, and 94 were removed due to being family-based studies (n = 31) and providing insufficient data (n = 61). Since HWE P ≤0.05 indicated the disturbance of mutation, nonrandom mating, natural selection, genetic drift, and gene flow, six studies not meeting the HWE P>0.05 criteria were excluded. Therefore, the remaining 10 manuscripts were included in the analysis.
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The gene frequencies of five different genetic models were calculated in Table 1 . The selected 10 articles were used for calculating allelic, recessive, dominant, homozygous, and heterozygous genetic models. However, one of the 10 articles 22 included the number of case-controls and the gene frequency of G and C but did not include the detailed number of GG, GC, CC (Table 1) .
Therefore, data from Lee et al 22 was included only in the allelic genetic model.
The detailed research data of 10 articles selected for the metaanalysis are recorded in Table 2 . The meta-analysis included 10
articles with a total of 19 921 subjects (RA: 5735 control: 14 186).
All research designs were case-control studies, with subjects ranging in age from 22 to 65 years, with numbers ranging from 177 to 8719. The study included six articles on Asian populations, five on
European populations, and one on a North American population. The STREGA scores of the 10 articles ranged from 7 to 11 out of a total of 12 (Table 2 ). These scores indicate that the article quality is sufficient to incorporate into a meta-analysis. The KARE study did not include a quality score of the article since the association analysis of PTPN22-1123 and RA was not previously published. However, the genetic data of PTPN22-1123 were available in the Ansan/Ansung cohort in the KARE study. The authors conducted a genetic association analysis, but no publication was available. Since the KARE study was a high-quality well-controlled cohort study with 8719 middleaged adults, the quality of the study was sufficient to be included in the meta-analysis (Table 2) .
Each article described in Table 3 was evaluated by HWE. There were 9 articles with HWE P >0.05, and KARE data also had P >0.05
for HWE. One could not be calculated because there was no detailed GG, GC, and CC distribution. In Table 3 , the conclusions of the authors in each article are summarized. Thus, PTPN22-1123 was associated with RA in five studies, [15] [16] [17] and there was no relevant association of PTPN22-1123 with RA in four studies.
21,22
| Heterogeneity analysis
The heterogeneity in various genetic models is mainly shown in Table 4 . I 2 , an index of heterogeneity, was 77%, 65%, 64%, 72%, and 48%, in the allelic, recessive, dominant, homozygous, and heterozygous genetic models, respectively. When I 2 was greater than 40% (P < 0.05), the random model was used. However, in the subgroup analysis, the random model was used in all genetic models of Asians since the I 2 was more than 40% (P < 0.05). By contrast,
I
2 in the non-Asian group was <40% (P > 0.05) and the fixed model was considered for the non-Asian group (Table 4) . However, the Asians and non-Asians were simultaneously analyzed in the same model for subgroup analysis using Review manager 5.3 (Cochrane Community, London, UK). The random model was used in the subgroup analysis (Table 4) . When the non-Asian studies were separately analyzed in fixed genetic models, the statistical analysis was not changed from the random genetic models.
| Association of PTPN22-1123 genotype and RA risk
Regarding the relationship between PTPN22-1123and RA risk, we analyzed the OR and 95% CI for pooling 10 selected articles by Review
Manager. The results of all 10 articles are summarized in Table 4 . The and (e) heterozygous genetic model: 1.23 (0.98-1.54) (P = 0.06). The results of the genetic models indicated that the subjects with risk allele (C) were at increased risk of RA when all 10 articles were pooled compared with those with subjects with the non-risk allele (G).
In addition, a subgroup analysis was performed on the possible differences between ethnicities. According to the ethnicity of the subjects, the study was divided into Asian groups, such as China, South Korea 16,21,22,24,25 and non-Asian groups, such as Norway, France, the UK, Mexico. 15, 17, 18, 23 The ORs (CIs; P value) of the subgroup analysis are shown in Table 4 
| Sensitivity analysis
In order to exclude the single study, if the overall analysis results were affected by a single study, the results of pooling 10 studies might include some bias. In a sensitivity analysis, no single study influenced the overall analysis. The results confirmed that PTPN22
was significantly associated with RA.
| Publication bias
The regression analysis of the Egger test was analyzed in the five genetic models (the allelic, recessive, dominant, homozygous, and heterozygous genetic models), and the results are shown in Table 4 of the test for publication bias. There was no publication bias in overall studies and subgroups including the Asian and non-Asian groups in the allelic, recessive, dominant, and homozygous genetic models in
Eager test (Table 4) 
| D ISCUSS I ON
Some studies include small numbers of subjects suffering from RA and lack the statistical power to attain statistical significance to explore the impact of the genetic variant. 28 Meta-analyses rule out false positives and false negatives that may result from a single study by pooling the data from several studies.
The present study confirmed that carrying the C allele of the PTPN22 is known to affect the receptor response of B cells
and T cells and its mutation increases or decreases the risk of autoimmune diseases. 29 In 2004 the association between PTPN22
Trp620 and type 1 diabetes was first the gene identified as an important genetic risk factor for autoimmune diseases. 30 Hasegawa in 2004 also demonstrated that PTPN22 knock-out mice develop immune abnormalities such as increased antibody titers and increases in T cell subsets. 31 The hyperactive immune system is accompanied by changes in the phosphorylation state of protein tyrosine kinases, indicating PTPN22 is genetically associated with human autoimmunity. 32 In previous studies, PTPN22 mutation site +1858 C/T is found to be associated with RA. 33 Hinks et al have also reported that PTPN22 is associated with susceptibility to RA. RA susceptibility. [15] [16] [17] [18] In the subgroup analysis, there was large heterogeneity in the Asian group, and there was no significant difference in the association between PTPN22-1123 and RA among Asians (P > 0.05). However, there were statistically significant associations in the non-Asian group (P < 0.05) in the present study. PTPN22-1123
is not a risk site for RA in Asians but is a genetic risk variant for non-Asians.
Heterogeneity and publication bias of articles are a key issues affecting the reliability of meta-analyses, but the meta-analysis methodology is also constantly improving. 37 Publication bias existed in the Asian group, not in the non-Asian group, suggesting that since PTPN22-1123 may not influence RA risk there may be a tendency to not publish the negative results in studies such as the KARE study in Korea. We were unable to find any publications about the association between PTPN22-1123 and RA risk for Koreans. However, we did find articles about the "diagnosis of RA" and "PTPN22-1123" and their association was not statistically significant. Therefore, Korean researchers have not devoted much attention to PTPN22-1123 and have not published research investigating the link to RA. That could also happen in other countries and it can lead to publication bias.
Differences in age and gender between the subjects in different articles can also lead to heterogeneity. When pooling the articles, age and gender differences developed some heterogeneity.
Since there could be intra-study differences in self-identification of autoimmune diseases that we were unable to account for when all studies are combined, the results may be inaccurate. Therefore, we conducted a stratified analysis according to ethnic regions. Although this can avoid heterogeneity to the greatest extent, at the same time, due to the reduction in the number of studies included in the grouping, the statistical power is limited and it is not sufficient to find weak effects. The etiology of autoimmune diseases is complex, and there is still no definitive conclusion about the factors that cause autoimmunity, which is influenced by many factors such as environment, psychology, and genes. It is still unclear whether evaluating the effects of a single genetic interaction on the disease is the best approach to studying it. Smoking increases the prevalence of RA, 38 which is not included in the 10 data sets used in the meta-analysis.
There are some limitations to the present study. and BMI were mixed in each study, the subjects could not be separated to conduct subgroup analysis. Environmental risk factors such as nutrient intake and lifestyle factors were involved in RA incidence, but they could not be used for subgroup analysis. The data for each risk factor were not provided and could not be used to conduct subgroup analysis. Therefore, we conducted the subgroup analysis by ethnicity only in the meta-analysis. Second, RA is affected by complex genes interactions, but we studied a single SNP from PTPN22 and the results were not adjusted for genetic variant-environmental factor interactions, although environmental factors such as nutrient intake, smoking, drinking, and physical activity can influence RA incidence. However, PTPN22-1123 may be an important factor which affects the risk of RA since genetic factors appear to be more crucial than environmental factors.
Finally, there was publication bias in the Asian group. It might be associated with the lack of significant association with the genetic variant and RA risk in Asians and the results might not be published. Thus, this publication bias might not change the conclusion of the present study.
F I G U R E 3 Funnel plot of selected studies in allelic genetic model of the meta-analysis. Circles and diamond shapes represent the studies of Asians and non-Asians, respectively
In conclusion, in the meta-analysis, PTPN22-1123 was significantly associated with RA in non-Asians, but not Asians. However, there are some important limitations in this study, so it is necessary to further study how PTPN22-1123 is associated with RA and how it interacts with environmental, lifestyle and other genetic effects. 
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